Drug
Cbd
Cbd: highest development phase Phase 2, developed by Jazz Pharmaceuticals. 2 trial records tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Jazz Pharmaceuticals
Trials
| Drug | Phase | Indication |
|---|---|---|
| CBD Oral Solution NCT06261502 | Phase 2 | Fragile X Syndrome |
| CBD Oral Solution (eCBD system Target) NCT06261450 | Phase 2 | Fragile X Syndrome |
Latest
No recent events.
Follow Cbd on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.